Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)
Phase of Trial: Phase I
Latest Information Update: 11 Nov 2015
At a glance
- Drugs Sarilumab (Primary) ; Tocilizumab
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- Sponsors Regeneron Pharmaceuticals
- 04 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 12 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 12 Mar 2015 Planned End Date changed from 1 Mar 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov record.